Cam Gallagher, President at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 12,500 shares at $22.72 ($285K) on 2022-11-15, disclosed to the SEC on 2022-11-15.
Open-market sale of $285k ZNTL by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.72 | 11,600 | $264K | 92.6% |
| 2 | $23.48 | 900 | $21K | 7.4% |
| Total | $22.77 avg | 12,500 | $285K | 100% |
| Filing → |
| ZNTL | SELL | 2024-02-12 | $13K | — | Filing → |
| ZNTL | SELL | 2024-02-05 | $267K | — | Filing → |
| ZNTL | SELL | 2023-05-31 | $1.5M | — | Filing → |